amfAR, The Foundation for AIDS Research

amfAR Welcomes Mark Dybul as New Global Fund Executive Director

Foundation pledges to work with Dybul to help fulfill Global Fund’s mission, create an ‘AIDS-free generation’

For Immediate Release

Media Contact:
Cub Barrett, Program Communications Manager
cell: (847) 571-0509
cub.barrett@amfar.org 

NEW YORK, November 15, 2012—amfAR, The Foundation for AIDS Research on Thursday welcomed the selection of Ambassador Mark Dybul to be the new executive director of The Global Fund to Fight AIDS, Tuberculosis and Malaria.

Dybul played a key role in establishing and leading the President’s Emergency Plan for AIDS Relief (PEPFAR) as the first head of the Office of the Global AIDS Coordinator (OGAC). Since its inception in 2003, PEPFAR has become the largest bilateral effort aimed at a single disease in history.

“Mark Dybul’s track record of delivering results is exactly what we need at the Global Fund,” said amfAR CEO Kevin Robert Frost. “We look forward to working with him to reach our shared goal of an ‘AIDS-free generation’.”

Since its inception in 2002, the Global Fund has helped save more than 8.7 million lives. According to the Fund, its programs have delivered lifesaving treatment to 3.6 million people living with HIV, detected and treated 9.3 million cases of tuberculosis, and distributed 270 million mosquito nets to protect families from malaria.

“Ambassador Dybul is a passionate advocate for global health with the talent and experience needed to take advantage of the opportunity of the moment,” said Owen Ryan, amfAR’s deputy director of public policy and an alternate board member of the Global Fund. “For the first time we see a path to beginning to end the death and illness caused by AIDS, TB, and malaria.  I believe Mark Dybul will provide the leadership necessary to help the Global Fund accelerate success on all these diseases.”

About amfAR  

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of sound AIDS-related public policy. Since 1985, amfAR has invested more than $366 million in its programs and has awarded grants to more than 2,000 research teams worldwide.